Simply Oncology
Welcome to Simply Oncology.
Cancer is daunting for both patients and for clinical teams.
Dr John McGrane and Dr Michael Rowe are oncologists who want to break down the complex parts of cancer care into clear and simple sessions.
We will dive deep into the world of cancer research, patient stories and the latest cancer breakthroughs.
Simply Oncology will have patient focused episodes along with episodes that allow anyone with an interest in oncology to stay up to date.
We hope you join us as we unpick all parts of cancer.
John & Mike
Simply Oncology
Episode 49: In the Clinic - Erdafitinib & Enfortumab Vedotin in metastatic urothelial cancer with Professor Rob Jones
Part 2 of our discussion on bladder cancer with Professor Rob Jones.
We have new drug classes in Bladder cancer !!
We look at Erdafitinib which is coming in the post Immunotherapy space to NHS England.
We also look ahead to Antibody Drug Conjugates - in particular Enfortumab Vedotin - with EV 302 trial results and what access to this means for the UK bladder community.
These are exciting times and we discuss potential side effects of these classes of drugs and how we intend to use them.
Enjoy
.jpeg)